When was NEUROPHET founded?

NEUROPHET was founded in 2016 and raised its 1st funding round 3 years after it was founded.

Where is NEUROPHET located?

NEUROPHET is headquartered in Seoul, South Korea.

Who is the current CEO of NEUROPHET?

Junkil Been of NEUROPHET. They have also founded 1 company.

How many employees does NEUROPHET have?

As of Sep 30, 2026, the latest employee count at NEUROPHET is 78.

Is NEUROPHET a funded company?

NEUROPHET is a funded company, having raised a total of $24.4M across 5 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Nov 26, 2019.

When was the latest funding round of NEUROPHET?

NEUROPHET's latest funding was a $***** Post IPO round on Apr 13, 2026, with participation from 2 investors.

What is the annual revenue of NEUROPHET?

Annual revenue of NEUROPHET is between $1M and $10M as on Dec 31, 2024

Where does NEUROPHET rank among its competitors?

NEUROPHET ranks 1st amongst 82 active competitors, of which 31 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Omniscient, which secured $27.2M in May, 2026.

Who are the top competitors of NEUROPHET?

NEUROPHET's top competitors include BrainSightAI, RapidAI and Cortechs.ai. Among them, Omniscient secured the most recent funding round in May, 2026.

NEUROPHET - 2026 Company Profile, Team, Funding, Competitors & Financials

NEUROPHET is a public company based in Seoul (South Korea), founded in 2016 by Junkil Been. It operates as a Developer of AI-based simulation software for doctors and researchers in electrical brain stimulation. NEUROPHET has raised $24.4M in funding from investors like SBI Investment Korea, ES Investor and Samjin Pharm. The company has 82 active competitors, including 31 funded and 6 that have exited. Its top competitors include companies like BrainSightAI, RapidAI and Cortechs.ai.

Company Details

Developer of AI-based simulation software for doctors and researchers in electrical brain stimulation. It is developing simulation software in neuro-engineering that is specialized for doctors and researchers in electrical brain stimulation (EBS). Its users can generate an individual 3D brain model by MRI, and simulate and analyze the potential effects of EBS in the various parameters of treatment in a clinical setting. It helps with full-automatic 3D brain model generation for each patient.

Website: www.neurophet.com/en
Social
Email ID: *****@neurophet.com
Phone Number: +82 **********

Key Metrics

Founded Year

2016

Location

Seoul, South Korea

Stage

Public

Total Funding

$24.4M in 5 rounds

Latest Funding Round

Post IPO, Apr 13, 2026, $*****

Investors

SBI Investment Korea & 20 more

Ranked

1^st among 82 active competitors

Annual Revenue

$1M - $10M as on Dec 31, 2024

Employee Count

78 as on Sep 30, 2026

Similar Companies

OpenEvidence & 2906 more

Exit Details

Public

View NEUROPHET's full profile

NEUROPHET is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Neurofit Co., Ltd. CIN: 204-86-57415 , South Korea, Active	Mar 13, 2016	$1M - $10M (As on Dec 31, 2024)	-	-

NEUROPHET got listed on Jul 25, 2025.

Click here to take a look at NEUROPHET's IPO in detail

NEUROPHET has raised a total funding of $24.4M over 5 rounds. Its first funding round was on Nov 26, 2019. Its latest funding round was a Post IPO round on Apr 13, 2026 for $*****. 2 investors participated in its latest round. NEUROPHET has 21 institutional investors.

Here is the list of recent funding rounds of NEUROPHET:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 13, 2026	2720470	Post IPO	9798949	5829377	2786960	9587029
Mar 04, 2024	1913715	Series B	5046189	6041358	4754387	4776534
Nov 08, 2021	1288259	Series B	7982921	1696196	SBI Investment Korea & 5 more	7174337

Access funding benchmarks and valuations. Sign up today!

View details of NEUROPHET's funding rounds and investors

The founders of NEUROPHET is Junkil Been. Junkil Been is the CEO of NEUROPHET.

Here are the details of NEUROPHET's key team members:

Junkil Been: Co-Founder & Co-CEO of NEUROPHET.

View details of NEUROPHET's Founder profiles and Board Members

NEUROPHET's employee count trend

NEUROPHET has 78 employees as of Sep 26. Here is NEUROPHET's employee count trend over the years:

Uncover NEUROPHET's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NEUROPHET include BrainSightAI, RapidAI and Cortechs.ai. Here is the list of Top 10 competitors of NEUROPHET, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	NEUROPHET 2016, Seoul (South Korea), Public	Developer of AI-based simulation software for doctors and researchers in electrical brain stimulation	$24.4M	Philips HealthWorks, ES Investor & 19 others	61/100
2nd	BrainSightAI 2019, Bengaluru (India), Seed	AI based platform offering connectomics for functional brain mapping	$6.86M	Pfizer, Indian Angel Network & 51 others	60/100
3rd	RapidAI 2012, San Mateo (United States), Series C	Developer of clinical AI platform enhancing medical imaging and stroke care	$100M	Lennertz, Vistacreditpartners & 2 others	57/100
4th	Cortechs.ai 2001, San Diego (United States), Series C	Provider of AI-powered medical imaging analysis software	$9.07M	NIH, Europa & 2 others	56/100
5th	Cerebriu 2018, Copenhagen (Denmark), Series A	AI-based imaging software for the diagnosis of brain disease	$29.5M	Innovationsfonden, North Ventures & 9 others	56/100
6th	icometrix 2011, Leuven (Belgium), Acquired	Provider of an AI based software for analysis of brain MRI images	$20.2M	Forestay Capital, Capricorn Partners & 9 others	56/100
7th	Omniscient 2019, Sydney (Australia), Series D	Provider of AI-powered brain mapping and analysis platform	$60M	National Reconstruction Fund, OIF Ventures ... & 5 others	55/100
8th	Methinks 2016, Barcelona (Spain), Seed	Provider of AI and cloud-based software for the diagnosis of strokes	-	EIC Fund, Aei & 4 others	52/100
9th	Jvion 2011, Suwanee (United States), Acquired	Provider of a deep learning-based solution for predicting illness	$11.1M	Trinity Health, JMI Management & 7 others	43/100
10th	AI Innovatech 2019, Houston (United States), Seed	Provider of an AI-enabled medical image processing platform for detecting diseases	$2.8M	PioneerCrest	42/100